Improve Markers of Oxidative Stress and Coagulation Parameters in Response to Atorvastatin Therapy

References (49)

1. 1 [30] Microsomal lipid peroxidation [DOI]
2. 2 Assessment of current diagnostic criteria for Guillain-Barr� syndrome [DOI]
3. 3 The estimation of red cell superoxide dismutase activity.
4. 4 Peripheral neuropathies and anti-glycolipid antibodies [DOI]
5. 5 Randomised trial of plasma exchange, intravenous immunoglobulin and combined treatments in guillain-barre syndrome [DOI]
6. 6 Guillain-Barré syndrome [DOI]
7. 7 Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia [DOI]
8. 8 HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis [DOI]
9. 9 Antiphospholipid antibodies and thrombosis [DOI]
10. 10 Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
11. 11 Lipid peroxides induce expression of catalase in cultured vascular cells [DOI]
12. 12 Antioxidant effect of aqueous extract of the bark of Ficus bengalensis in hypercholesterolaemic rabbits [DOI]
13. 13 Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.
14. 14 HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins [DOI]
15. 15 Hyperuricemia induces endothelial dysfunction via mitochondrial Na+/Ca2+ exchanger-mediated mitochondrial calcium overload [DOI]
16. 16 Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia [DOI]
17. 17 CNS dysfunction in the antiphospholipid syndrome [DOI]
18. 18 Assessing the Usefulness of Anticardiolipin Antibody Assays [DOI]
19. 19 8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA damage in a rural prediabetes cohort [DOI]
20. 20 The effect of ethanol extract of Hypericum lysimachioides on lipid profile in hypercholesterolemic rabbits and its in vitro antioxidant activity [DOI]
21. 21 Antiphospholipid antibodies in pediatric patients with prolonged activated partial thromboplastin time during infection [DOI]
22. 22 Relationship between mean platelet volume and low-grade systemic coagulation with vitamin D deficiency in primary ovarian insufficiency [DOI]
23. 23 Oxidative DNA damage: antioxidant response in postprandial hyperglycaemia in type 2 diabetes mellitus [DOI]
24. 24 Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxidases in cytoprotection against lipid hydroperoxide- and iron-mediated reactions. [DOI]
25. 25 Similar Effects of Atorvastatin, Simvastatin and Pravastatin on Thrombogenic and Inflammatory Parameters in Patients with Hypercholesterolemia [DOI]
26. 26 Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies [DOI]
27. 27 Practical Haematology [DOI]
28. 28 Comparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemia [DOI]
29. 29 Effects of Statins on Oxidative Stress [DOI]
30. 30 Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA [DOI]
31. 31 HMG-CoA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxide [DOI]
32. 32 Increased Fibrinogen Levels and Acquired Hypofibrinolysis in Young Adults With Ischemic Stroke [DOI]
33. 33 Antioxidant activity of ezetimibe in hypercholesterolemic rats [DOI]
34. 34 Hyperuricemia Is a Mediator of Endothelial Dysfunction and Inflammation in Renal Allograft Recipients [DOI]
35. 35 Antiatherosclerotic potential of aliskiren: its antioxidant and anti-inflammatory effects in rabbits: a randomized controlled trial [DOI]
36. 36 The antiphospholipid (Hughes') syndrome: changing the face of neurology [DOI]
37. 37 Anti-phospholipid antibodies in serum from patients with Guillain-Barré syndrome [DOI]
38. 38 Effects of Atorvastatin on Red-blood Cell Na+/Li+ Countertransport in Hyperlipidemic Patients With and Without Hypertension [DOI]
39. 39 Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause?
40. 40 ANTIPHOSPHOLIPID ANTIBODIES [DOI]
41. 41 Effect of cholesterol-rich diets with and without added vitamins E and C on the severity of atherosclerosis in rabbits [DOI]
42. 42 Autoantibodies to Phospholipids and Brain Extract in Patients with the Guillain-Barre Syndrome: Cross-Reactive or Pathogenic? [DOI]
43. 43 Antithrombotic actions of statins.
44. 44 Anti‐GM1, anti‐central myelin proteins, and anti‐cardiolipin autoantibodies during plasma‐exchange in Guillain‐Barré syndrome (GBS) [DOI]
45. 45 HYPERURICEMIA IS A MEDIATOR OF ENDOTHELIAL DYSFUNCTION AND INFLAMMATION IN RENAL ALLOGRAFT RECIPIENTS [DOI]
46. 46 Relationship between Prothrombin Activation Fragment F1 +2 and Serum Cholesterol [DOI]
47. 47 Comparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemia [DOI]
48. 48 Statins and fibrinogen [DOI]
49. 49 Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes?

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Salivary Lipid Peroxidation and Antioxidant Status in Nigerian Cigarette Smokers with or Without Periodontitis — shares topic coverage
• Profile of Biochemical and Oxidative Stress Markers in Male Athletes Following Strenuous Exercise Session — shares topic coverage
• Atherogenicity, Oxidative Stress, Heavy Metals and Bioelements Status in Hypertensive Nigerians in an Urban Population — shares topic coverage
• Oxidative Stress Biomarkers (Malondialdehyde, Superoxide Dismutase, and Catalase) as Predictors of Cardiovascular Disease Risk: A Review — shares topic coverage
• Ebselen a Seleno-organic Molecule Inhibits Alteration in the Biological Responses in Hypoxic Human Alveolar Lung Epithelial Cells — shares topic coverage